China Pharma Holdings, Inc.
China Pharma Holdings, Inc. (CPHI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CPHI · as of Dec 31, 2021
Ownership Breakdown
8
Institutional Holders
▲ 1 vs Q3
$425,114
Total Inst. Value
▼ $271,494 vs Q3
3.18M
Shares Outstanding
freeFloat 73.64%
882,354
13F Shares Held
▼ 365,955 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CPHI largest shareholders · institutional ownership
Q4 2021 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 460.2K | 1.93% | 1.93% | $222.00M | Feb 11, 2022 | ▼ 240.4K |
BRIDGEWAY CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 195.0K | 0.82% | 0.82% | $94.00M | Feb 14, 2022 | — held |
VIRTU FINANCIAL LLC pharmaceutical preparations | 105.3K | 0.44% | 0.44% | $51.00M | Feb 17, 2022 | ▲ 72.2K |
HRT FINANCIAL LP pharmaceutical preparations | 62.9K | 0.26% | 0.26% | $30.00M | Feb 14, 2022 | ▼ 220.0K |
TWO SIGMA ADVISERS, LP pharmaceutical preparations | 31.6K | 0.13% | 0.13% | $15.00M | Feb 14, 2022 | ▲ 17.4K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 23.0K | 0.10% | 0.10% | $11.00M | Apr 5, 2022 | NEW |
SAMALIN INVESTMENT COUNSEL, LLC pharmaceutical preparations | 2.9K | 0.01% | 0.01% | $1.39M | Feb 15, 2022 | — held |
FIRST COMMUNITY TRUST NA pharmaceutical preparations | 1.5K | 0.01% | 0.01% | $724,000 | Feb 16, 2022 | NEW |
UBS GROUP AG pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2022 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2022 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2021 vs prior quarter
Q4 2021
2
Increased
+89.6K shares2
New Positions
first time holders2
Decreased
−460.5K shares3
Sold Out
fully exitedNet shares change (top 50)
370.9K
+89.6K / −460.5K
Net new holders
-1
2 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CPHI insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Li Zhilin CEO & Interim CFO | Sep 29, 2023 | Award | 13,757,063 | $0.14 | $1.93M | 15.14M | Form 4 ↗ |
Li Zhilin CEO & Interim CFO | Sep 9, 2021 | Award | 1,760,000 | $0.67 | $1.18M | 13.81M | Form 4 ↗ |
Li Zhilin CEO and interim CFO | Dec 23, 2020 | Award | 2,000,000 | — | — | 12.05M | Form 4 ↗ |
WAUNG FRANK Chief Financial Officer | Apr 28, 2012 | Award | 100,000 | — | — | 138.4K | Form 4 ↗ |
WAUNG FRANK Chief Financial Officer | May 25, 2011 | D-Return | 25,000 | $2.54 | $63.5K | 0 | Form 4 ↗ |
WAUNG FRANK Chief Financial Officer | Apr 28, 2010 | D-Return | 150,000 | $3.47 | $520.5K | 0 | Form 4 ↗ |
WAUNG FRANK Chief Financial Officer | Oct 13, 2009 | D-Return | 10,000 | $2.75 | $27.5K | 0 | Form 4 ↗ |
Li Zhilin President and CEO | May 25, 2011 | Award | 50,000 | — | — | 10.05M | Form 4 ↗ |
Li Zhilin President and CEO | May 25, 2011 | Award | 25,000 | $2.54 | $63.5K | 25.0K | Form 4 ↗ |
WAUNG FRANK Chief Financial Officer | May 25, 2011 | Award | 25,000 | — | — | 38.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
China Pharma Holdings, Inc. (CPHI) is primarily owned by institutional investors, who hold approximately 27.8% of total shares outstanding. Company insiders own approximately 26.36%, while retail and public investors account for the remaining 45.88%.
The largest institutional shareholder of China Pharma Holdings, Inc. is RENAISSANCE TECHNOLOGIES LLC, holding approximately 460,217 shares — equal to 1.93% of outstanding shares — as of December 31, 2021.
A total of 8 institutional investors currently hold CPHI stock, with a combined institutional value of approximately $425,114 as of the most recent 13F filing period.
Frequently asked questions
CPHI ownershipChina Pharma Holdings, Inc. (CPHI) is primarily owned by institutional investors, who hold approximately 27.8% of shares. The largest shareholder is RENAISSANCE TECHNOLOGIES LLC with a 1.93% stake. Company insiders hold 26.36%. Data sourced from SEC Form 13F as of December 31, 2021.